Brookwood Investment Group LLC decreased its position in Cigna Group (NYSE:CI – Free Report) by 17.3% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 825 shares of the health services provider’s stock after selling 172 shares during the period. Brookwood Investment Group LLC’s holdings in Cigna Group were worth $273,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Valeo Financial Advisors LLC lifted its position in Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after buying an additional 3,471,249 shares in the last quarter. Nuveen LLC purchased a new stake in Cigna Group in the 1st quarter worth approximately $727,905,000. Price T Rowe Associates Inc. MD lifted its position in Cigna Group by 10.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after buying an additional 1,094,327 shares in the last quarter. GQG Partners LLC lifted its position in Cigna Group by 21.5% in the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after buying an additional 865,092 shares in the last quarter. Finally, Goldman Sachs Group Inc. lifted its position in Cigna Group by 38.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock worth $542,796,000 after buying an additional 457,052 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.
Cigna Group Stock Performance
Shares of CI opened at $309.10 on Wednesday. The company has a market capitalization of $82.51 billion, a PE ratio of 16.87, a price-to-earnings-growth ratio of 0.91 and a beta of 0.45. Cigna Group has a one year low of $256.89 and a one year high of $350.00. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The company’s fifty day moving average price is $299.57 and its 200 day moving average price is $307.33.
Cigna Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be given a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 2.0%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is currently 32.97%.
Analyst Upgrades and Downgrades
CI has been the subject of a number of research analyst reports. Guggenheim reiterated a “buy” rating and issued a $350.00 target price (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Cigna Group in a research report on Wednesday, October 8th. Wells Fargo & Company increased their target price on shares of Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 7th. Wolfe Research cut their price target on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, October 15th. Finally, The Goldman Sachs Group started coverage on shares of Cigna Group in a research note on Tuesday, October 14th. They issued a “buy” rating and a $370.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $369.89.
Get Our Latest Stock Report on Cigna Group
Insider Buying and Selling at Cigna Group
In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider directly owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares in the company, valued at $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.70% of the company’s stock.
Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles
- Five stocks we like better than Cigna Group
- How Technical Indicators Can Help You Find Oversold StocksĀ
- The Drone Arms Race: From Battlefield to Balance Sheet
- What is a Microcap Stock? Everything You Need to Know
- Why Wall Street Is Backing These 3 Comeback Stocks
- How to Buy Cheap Stocks Step by Step
- Intel’s Breakout Quarter: More Than a Beat, It’s a Declaration
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
